Log In
Print
BCIQ
Print
Print this Print this
 

Combivent Respimat, ipratropium bromide/albuterol

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionIpratropium bromide and albuterol propellant-free inhaler
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today